192 related articles for article (PubMed ID: 24743288)
1. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
[TBL] [Abstract][Full Text] [Related]
3. [A case of an elderly patient with recurrent GIST, which was effectively treated with low-dose imatinib mesylate].
Matsumoto S; Takahashi M; Ishizu H; Takahashi H; Masuko H; Tanaka K; Hata T; Yamagami H; Takahashi S; Tahara M; Ueki S; Kuji M; Tanioka T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2405-7. PubMed ID: 25731538
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
[TBL] [Abstract][Full Text] [Related]
5. [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Kanazawa A; Tsukamoto T; Ikehara T; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):55-8. PubMed ID: 24423952
[TBL] [Abstract][Full Text] [Related]
6. [A case of recurrent gastrointestinal stromal tumor progressing after interruption of long-term imatinib therapy].
Nakatsuka R; Takahashi T; Miyazaki Y; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2478-80. PubMed ID: 25731563
[TBL] [Abstract][Full Text] [Related]
7. [A case of recurrent intestinal GIST with long-term survival-beneficial effect of multimodality therapy using high-dose imatinib and surgery].
Akasaka H; Koyama M; Yokoyama H; Morohashi H; Sakamoto Y; Murata A; Hakamada K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1975-7. PubMed ID: 23267948
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of imatinib for treatment of metastatic GIST.
Patel S
Cancer Chemother Pharmacol; 2013 Aug; 72(2):277-86. PubMed ID: 23503753
[TBL] [Abstract][Full Text] [Related]
9. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
Murakami M; Ebisui C; Okada K; Okamura S; Murata K; Nakagomi N; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2014 Jan; 41(1):99-101. PubMed ID: 24423961
[TBL] [Abstract][Full Text] [Related]
10. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
El Hajj II; Chehal A; El Saghir NS
Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
[No Abstract] [Full Text] [Related]
11. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
[TBL] [Abstract][Full Text] [Related]
12. [A case of small intestinal GIST maintained as a long stable disease by imatinib mesylate 400 mg/day, alternate-day administration for 2 weeks followed by a 2 week interval].
Nakamura T; Shiraishi S; Kitamura N; Taniguchi M; Okauchi H; Shimomatsuya T; Maruhashi K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1695-8. PubMed ID: 21996970
[TBL] [Abstract][Full Text] [Related]
13. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
[TBL] [Abstract][Full Text] [Related]
14. [Surgical resection of a huge gastric gastrointestinal stromal tumor after preoperative adjuvant chemotherapy].
Minami T; Hiramatsu K; Kato T; Shibata Y; Yoshihara M; Natsume S; Aoba T
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1163-6. PubMed ID: 25248904
[TBL] [Abstract][Full Text] [Related]
15. [A case of rectal gastrointestinal stromal tumor (GIST) locally resected after long-term chemotherapy with imatinib mesylate].
Tonooka T; Takiguchi N; Yamamoto H; Nabeya Y; Ikeda A; Kainuma O; Souda H; Cho A; Muto Y; Yanagibashi H; Takano E; Denda T; Nagata M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1849-51. PubMed ID: 25731351
[TBL] [Abstract][Full Text] [Related]
16. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of recurrent or metastatic gastrointestinal stromal tumor: surgery or not].
Shi YQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):225-7. PubMed ID: 22454163
[TBL] [Abstract][Full Text] [Related]
18. That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumor.
Tap WD; Schwartz GK
J Clin Oncol; 2014 May; 32(15):1543-6. PubMed ID: 24638004
[No Abstract] [Full Text] [Related]
19. [A case of giant gastric GIST with multiple hepatic metastases with long-term survival after multimodal therapy].
Hara H; Takahashi T; Miyazaki Y; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2399-401. PubMed ID: 25731536
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
